157 related articles for article (PubMed ID: 9539133)
1. Mutant human presenilin 1 protects presenilin 1 null mouse against embryonic lethality and elevates Abeta1-42/43 expression.
Qian S; Jiang P; Guan XM; Singh G; Trumbauer ME; Yu H; Chen HY; Van de Ploeg LH; Zheng H
Neuron; 1998 Mar; 20(3):611-7. PubMed ID: 9539133
[TBL] [Abstract][Full Text] [Related]
2. An Alzheimer's disease-linked PS1 variant rescues the developmental abnormalities of PS1-deficient embryos.
Davis JA; Naruse S; Chen H; Eckman C; Younkin S; Price DL; Borchelt DR; Sisodia SS; Wong PC
Neuron; 1998 Mar; 20(3):603-9. PubMed ID: 9539132
[TBL] [Abstract][Full Text] [Related]
3. Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo.
Borchelt DR; Thinakaran G; Eckman CB; Lee MK; Davenport F; Ratovitsky T; Prada CM; Kim G; Seekins S; Yager D; Slunt HH; Wang R; Seeger M; Levey AI; Gandy SE; Copeland NG; Jenkins NA; Price DL; Younkin SG; Sisodia SS
Neuron; 1996 Nov; 17(5):1005-13. PubMed ID: 8938131
[TBL] [Abstract][Full Text] [Related]
4. Skeletal and CNS defects in Presenilin-1-deficient mice.
Shen J; Bronson RT; Chen DF; Xia W; Selkoe DJ; Tonegawa S
Cell; 1997 May; 89(4):629-39. PubMed ID: 9160754
[TBL] [Abstract][Full Text] [Related]
5. The presenilin-1 familial Alzheimer disease mutant P117L impairs neurogenesis in the hippocampus of adult mice.
Wen PH; Hof PR; Chen X; Gluck K; Austin G; Younkin SG; Younkin LH; DeGasperi R; Gama Sosa MA; Robakis NK; Haroutunian V; Elder GA
Exp Neurol; 2004 Aug; 188(2):224-37. PubMed ID: 15246822
[TBL] [Abstract][Full Text] [Related]
6. Implications of presenilin 1 mutations in Alzheimer's disease.
Komano H; Sudoh S; Kawamura Y; Wang R; Yanagisawa K
Mech Ageing Dev; 1999 Mar; 107(3):281-98. PubMed ID: 10360683
[TBL] [Abstract][Full Text] [Related]
7. Dissociated phenotypes in presenilin transgenic mice define functionally distinct gamma-secretases.
Mastrangelo P; Mathews PM; Chishti MA; Schmidt SD; Gu Y; Yang J; Mazzella MJ; Coomaraswamy J; Horne P; Strome B; Pelly H; Levesque G; Ebeling C; Jiang Y; Nixon RA; Rozmahel R; Fraser PE; St George-Hyslop P; Carlson GA; Westaway D
Proc Natl Acad Sci U S A; 2005 Jun; 102(25):8972-7. PubMed ID: 15951428
[TBL] [Abstract][Full Text] [Related]
8. Developmental expression of wild-type and mutant presenilin-1 in hippocampal neurons from transgenic mice: evidence for novel species-specific properties of human presenilin-1.
Lévesque L; Annaert W; Craessaerts K; Mathews PM; Seeger M; Nixon RA; Van Leuven F; Gandy S; Westaway D; St George-Hyslop P; De Strooper B; Fraser PE
Mol Med; 1999 Aug; 5(8):542-54. PubMed ID: 10501657
[TBL] [Abstract][Full Text] [Related]
9. DNA microarray profiling of developing PS1-deficient mouse brain reveals complex and coregulated expression changes.
Mirnics ZK; Mirnics K; Terrano D; Lewis DA; Sisodia SS; Schor NF
Mol Psychiatry; 2003 Oct; 8(10):863-78. PubMed ID: 14515137
[TBL] [Abstract][Full Text] [Related]
10. Hyperaccumulation of FAD-linked presenilin 1 variants in vivo.
Lee MK; Borchelt DR; Kim G; Thinakaran G; Slunt HH; Ratovitski T; Martin LJ; Kittur A; Gandy S; Levey AI; Jenkins N; Copeland N; Price DL; Sisodia SS
Nat Med; 1997 Jul; 3(7):756-60. PubMed ID: 9212102
[TBL] [Abstract][Full Text] [Related]
11. Processing of wild-type and mutant familial Alzheimer's disease-associated presenilin-1 in cultured neurons.
Weihl CC; Ghadge GD; Miller RJ; Roos RP
J Neurochem; 1999 Jul; 73(1):31-40. PubMed ID: 10386952
[TBL] [Abstract][Full Text] [Related]
12. Wild-type presenilin 1 protects against Alzheimer disease mutation-induced amyloid pathology.
Wang R; Wang B; He W; Zheng H
J Biol Chem; 2006 Jun; 281(22):15330-6. PubMed ID: 16574645
[TBL] [Abstract][Full Text] [Related]
13. Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins.
Borchelt DR; Ratovitski T; van Lare J; Lee MK; Gonzales V; Jenkins NA; Copeland NG; Price DL; Sisodia SS
Neuron; 1997 Oct; 19(4):939-45. PubMed ID: 9354339
[TBL] [Abstract][Full Text] [Related]
14. Familial Alzheimer disease-linked mutations specifically disrupt Ca2+ leak function of presenilin 1.
Nelson O; Tu H; Lei T; Bentahir M; de Strooper B; Bezprozvanny I
J Clin Invest; 2007 May; 117(5):1230-9. PubMed ID: 17431506
[TBL] [Abstract][Full Text] [Related]
15. Expression of a familial Alzheimer's disease-linked presenilin-1 variant enhances perforant pathway lesion-induced neuronal loss in the entorhinal cortex.
Lazarov O; Peterson LD; Peterson DA; Sisodia SS
J Neurosci; 2006 Jan; 26(2):429-34. PubMed ID: 16407539
[TBL] [Abstract][Full Text] [Related]
16. Synaptic transmission and hippocampal long-term potentiation in transgenic mice expressing FAD-linked presenilin 1.
Parent A; Linden DJ; Sisodia SS; Borchelt DR
Neurobiol Dis; 1999 Feb; 6(1):56-62. PubMed ID: 10078973
[TBL] [Abstract][Full Text] [Related]
17. Reduced antioxidant enzyme activity in brains of mice transgenic for human presenilin-1 with single or multiple mutations.
Leutner S; Czech C; Schindowski K; Touchet N; Eckert A; Müller WE
Neurosci Lett; 2000 Oct; 292(2):87-90. PubMed ID: 10998555
[TBL] [Abstract][Full Text] [Related]
18. Staurosporine-induced activation of caspase-3 is potentiated by presenilin 1 familial Alzheimer's disease mutations in human neuroglioma cells.
Kovacs DM; Mancini R; Henderson J; Na SJ; Schmidt SD; Kim TW; Tanzi RE
J Neurochem; 1999 Dec; 73(6):2278-85. PubMed ID: 10582585
[TBL] [Abstract][Full Text] [Related]
19. Mice lacking both presenilin genes exhibit early embryonic patterning defects.
Donoviel DB; Hadjantonakis AK; Ikeda M; Zheng H; Hyslop PS; Bernstein A
Genes Dev; 1999 Nov; 13(21):2801-10. PubMed ID: 10557208
[TBL] [Abstract][Full Text] [Related]
20. Differential display analysis of presenilin 1-deficient mouse brains.
Liauw J; Nguyen V; Huang J; St George-Hyslop P; Rozmahel R
Brain Res Mol Brain Res; 2002 Dec; 109(1-2):56-62. PubMed ID: 12531515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
